Anterix Inc. (NASDAQ:ATEX) Position Boosted by Gamco Investors INC. ET AL

Gamco Investors INC. ET AL increased its holdings in Anterix Inc. (NASDAQ:ATEXFree Report) by 24.2% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 93,295 shares of the company’s stock after buying an additional 18,195 shares during the quarter. Gamco Investors INC. ET AL owned about 0.50% of Anterix worth $3,136,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Roubaix Capital LLC grew its holdings in Anterix by 7.0% in the 1st quarter. Roubaix Capital LLC now owns 178,543 shares of the company’s stock worth $6,001,000 after buying an additional 11,666 shares in the last quarter. Clearbridge Investments LLC grew its holdings in Anterix by 2.2% in the 1st quarter. Clearbridge Investments LLC now owns 318,021 shares of the company’s stock worth $10,689,000 after buying an additional 6,844 shares in the last quarter. Vanguard Group Inc. boosted its stake in Anterix by 0.9% during the 1st quarter. Vanguard Group Inc. now owns 876,015 shares of the company’s stock valued at $29,443,000 after purchasing an additional 8,020 shares in the last quarter. Motco bought a new position in Anterix during the 1st quarter valued at $44,000. Finally, Woodmont Investment Counsel LLC boosted its stake in Anterix by 4.2% during the 1st quarter. Woodmont Investment Counsel LLC now owns 32,248 shares of the company’s stock valued at $1,084,000 after purchasing an additional 1,314 shares in the last quarter. 87.67% of the stock is owned by institutional investors.

Anterix Stock Up 1.0 %

NASDAQ ATEX traded up $0.39 on Friday, reaching $40.27. 56,560 shares of the stock traded hands, compared to its average volume of 166,813. The firm’s fifty day simple moving average is $35.52 and its 200 day simple moving average is $33.98. The company has a market cap of $747.81 million, a price-to-earnings ratio of -82.18 and a beta of 0.86. Anterix Inc. has a 12 month low of $27.20 and a 12 month high of $42.41.

Anterix (NASDAQ:ATEXGet Free Report) last issued its quarterly earnings results on Wednesday, June 26th. The company reported ($0.51) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.24) by ($0.27). The firm had revenue of $1.26 million for the quarter, compared to the consensus estimate of $1.52 million. Anterix had a negative net margin of 217.80% and a negative return on equity of 18.84%. As a group, equities research analysts forecast that Anterix Inc. will post -2.02 EPS for the current fiscal year.

Insider Transactions at Anterix

In other news, CFO Timothy Gray sold 16,667 shares of the firm’s stock in a transaction on Thursday, May 2nd. The stock was sold at an average price of $31.91, for a total transaction of $531,843.97. Following the completion of the sale, the chief financial officer now directly owns 90,475 shares of the company’s stock, valued at approximately $2,887,057.25. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 45.61% of the company’s stock.

Anterix Profile

(Free Report)

Anterix Inc operates as a wireless communications company. The company focuses on commercializing its spectrum assets to enable the targeted utility and critical infrastructure customers to deploy private broadband networks and innovative broadband solutions. It holds licensed spectrum in the 900 MHz band with coverage throughout the United States, Alaska, Hawaii, and Puerto Rico.

Featured Articles

Want to see what other hedge funds are holding ATEX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anterix Inc. (NASDAQ:ATEXFree Report).

Institutional Ownership by Quarter for Anterix (NASDAQ:ATEX)

Receive News & Ratings for Anterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anterix and related companies with MarketBeat.com's FREE daily email newsletter.